loader
Please Wait
Applying Filters...

Seqens Seqens

X

List of All Manufacturers & Suppliers for 2248611 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 ATAZANAVIR (ATAZANAVIR SULFATE) (1)

filter

01 BRISTOL-MYERS SQUIBB CANADA (1)

filter

01 CAPSULE (1)

filter

01 200MG (1)

filter

01 Canada (1)

URL Supplier Web Content
CAPSULE
200MG
REYATAZ
Canada
2248611
60
Prescription
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for CTD TGA MCC DOSSIER APPLICATION 2248611

Looking for CTD TGA MCC DOSSIER APPLICATION 2248611 1

19

Bristol Myers Squibb, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is ATAZANAVIR (ATAZANAVIR SULFATE), with a corresponding application number 2248611 and regulatory information .

proudly manufactured in the

Bristol Myers Squibb's REYATAZ CAPSULE, medication with 200MG of ATAZANAVIR (ATAZANAVIR SULFATE).

Post Enquiry
POST ENQUIRY